las41005
Small moleculeexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Jun 1, 2008 (NCT00987246)
Timeline
Indications
Studied for
Mechanism of action
- Uracil-DNA glycosylaseANTAGONIST
UNG antagonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- las41005
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01358851 | Phase 2 | Apr 1, 2011 | Almirall |
| NCT00987246 | Phase 3 | Jun 1, 2008 | Almirall |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Almirall | For profit | 2 | 2 | 2 | 2008 |
1 organizations
Page 1 / 1